Using f2 for compounds that never reach 85% dissolution [Dissolution / BCS / IVIVC]

posted by nobody – 2017-01-03 20:19 (3455 d 16:25 ago) – Posting: # 16924
Views: 8,006

Hi!

As the experts are apparently still on holiday :-) I might start with some questions/remarks.

Liposomes with doxorubicin (just wild guessing here ;-) ) are no oral formulation afaik. Why would you do dissolution testing (simulation GI tract, normally)?

The fraction of dose you get into solution pretty much depends on the media you use for your testing, in my opinion.

So maybe some more details on the kind of products/projects your on might be helpful to get more response. :-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
126 visitors (0 registered, 126 guests [including 16 identified bots]).
Forum time: 13:44 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5